Angiomyolipoma: Clinical Trials

3 trials for Angiomyolipoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Angiomyolipoma: new trials by email Literature Review of Angiomyolipoma trials Research Report on Angiomyolipoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Everolimus - Renal Angiomyolipoma
Phase 4CompletedNovartis Pharmaceuticals102023-05-012026-11-09
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Everolimus - Renal Angiomyolipoma
Phase 4CompletedNovartis Pharmaceuticals402018-11-092021-09-09
Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Sirolimus - Angiomyolipoma
Phase 4CompletedFundacio Puigvert182008-10-012012-03-08

Narrower conditions

Tuberous Sclerosis (2)  ·  Lymphangioleiomyomatosis (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Adipose Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Perivascular Epithelioid Cell Neoplasms (3)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hamartoma (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Malformations of Cortical Development (2)  ·  Malformations of Cortical Development, Group I (2)  ·  Neoplasms, Multiple Primary (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Nervous System Diseases (2)

Interventions

Everolimus (2)  ·  Sirolimus (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  Fundacio Puigvert (1)

Countries

China (1)  ·  Taiwan (1)

Top investigators

Roser Torra, MD,PhD (1)

Results publications

PMID 23140536